Survival improvement in thoracic cancer: progress from the last decade and beyond
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
Global cancer statistics
2011 • 55,498 citations
Global Cancer Statistics, 2002
2005 • 17,966 citations
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 • 2,871 citations
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 • 2,376 citations
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
2006 • 1,691 citations
The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts
2005 • 425 citations
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001
2004 • 364 citations
The changing epidemiology of lung cancer in Europe
2003 • 301 citations
Cited By (0)
No citing papers found in database